CLASS II Device recall · Reported 9 Sep 2015 · FDA Enforcement Report
MicroVue Bb Plus EIA is packaged as a kit which contains recalled
Diagnostic Hybrids is recalling MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to, distributed in 11 states. The recall was initiated on 16 Oct 2014 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-0417-2015
- FDA event ID
- 69545
- Recalling firm
- Diagnostic Hybrids, Athens, OH
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 16 Oct 2014
- FDA classified
- 3 Sep 2015
- Reported
- 9 Sep 2015
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Packaging Defects
- Device type
- Test Kits & Diagnostics
Timeline
| 16 Oct 2014 | Recall initiated by company | |
| 3 Sep 2015 | Classified by FDA | +322 days |
| 9 Sep 2015 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically documented.
Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.
Product as listed by the FDA
MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro diagnostic.
Where it was distributed
Worldwide Distribution - USA, including AL, CO, CT, FL, KY, MN, NC, NV, OH, PA, and WA; and, the countries of Canada, China, India, and Switzerland.
AlabamaColoradoConnecticutFloridaKentuckyMinnesotaNorth CarolinaNevadaOhioPennsylvaniaWashington
Questions about this recall
Is MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to recalled?
Yes. Diagnostic Hybrids recalled MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to on 16 Oct 2014. The recall is Class II and its status is Terminated. Recall number Z-0417-2015.
Why was it recalled?
Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically documented.
Which lots are affected?
Model Number A027; Lot Number 018186; (self-affixed, EDMA Code: 12 01 02 04 00; Complement Component Bb)
Where was it sold?
Worldwide Distribution - USA, including AL, CO, CT, FL, KY, MN, NC, NV, OH, PA, and WA; and, the countries of Canada, China, India, and Switzerland.
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Diagnostic Hybrids
All 8| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | MicroVue BAP EIA recalled by Diagnostic Hybrids | Diagnostic Hybrids | Packaging Defects | 12 states |
| Device | CLASS III | MicroVue CIC-C1q EIA recalled by Diagnostic Hybrids | Diagnostic Hybrids | Other | Nationwide |
| Device | CLASS III | MicroVue SC5b-9 Plus EIA (RUO) recalled by Diagnostic Hybrids | Diagnostic Hybrids | Potency & Assay | Nationwide |
| Device | CLASS III | MicroVue SC5b-9 Plus EIA (Ce-ivd) recalled by Diagnostic Hybrids | Diagnostic Hybrids | Potency & Assay | Nationwide |
| Device | CLASS II | MicroVue CIC-C1q EIA recalled by Diagnostic Hybrids | Diagnostic Hybrids | Potency & Assay | 4 states |
Other Test Kits & Diagnostics recalls
All 2,656| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | STA Staclot Protein S recalled by Diagnostica Stago | Diagnostica Stago | Potency & Assay | Nationwide |
| Device | CLASS II | DxC 500i Clinical Analyzer Modules using recalled by Beckman Coulter | Beckman Coulter | Packaging Defects | Nationwide |
| Device | CLASS II | DxC 500 AU Clinical Analyzer Modules using recalled by Beckman Coulter | Beckman Coulter | Packaging Defects | Nationwide |
| Device | CLASS II | Syva EMIT 2000 Quinidine Assay recalled | Siemens Healthcare Diagnostics | Lead & Heavy Metals | Nationwide |
| Device | CLASS II | Beckman Coulter, Emit 2000 Quinidine Assay recalled | Siemens Healthcare Diagnostics | Lead & Heavy Metals | Nationwide |